Inserm Transfert and M2care sign partnership agreement

Share :

Inserm Transfert, a subsidiary of Inserm dedicated to technology transfer, and M2care are partnering to support the development of innovative start-ups emerging from Inserm laboratories. This partnership aims to combine the excellence of academic research with entrepreneurial expertise to transform scientific discoveries into clinical innovations beneficial to patients and public health. Together, they aim to create deeptech start-ups in healthtech, providing financial, strategic, and operational support to promising projects.

« M2care is committed to thoroughly examining projects from Inserm Transfert's portfolio, perfectly aligned with our investment philosophy. This partnership strengthens our ability to conduct preliminary analyses on valorization strategies and enrich our project pipeline with high-quality projects while sharing best practices in the field. »
Florence Thueux
CEO M2care

More news

SEPSI Score: promising results from the retrospective study

The results of the retrospective study conducted on more than 5,200 stays show that SEPSI Score©, integrated into the hospital information system, analyzes in

M2care raises 20 millions euros

M2care is proud to announce the closing of its first financing round of €20 million. This round of financing is being carried out in

Inserm Transfert and M2care sign partnership agreement

Inserm Transfert, a subsidiary of Inserm dedicated to technology transfer, and M2care are partnering to support the development of innovative start-ups emerging from Inserm

Collaboration between Rhovica Neuroimaging and M2care for the Advancement of Neurosurgery

Rhovica Neuroimaging was founded in Bern, Switzerland, in 2023 by Martin Hlavica and Thomas Rhomberg, two talented neurosurgeons. Their ambition is to improve the

TheraSonic wins the Grand-Prix iLab!

A victory for health innovation, an innovative project rewarded. We are extremely proud to announce that TheraSonic, a startup co-founded and funded by M2care,

M2care announces the creation of TheraSonic

Therasonic is a deeptech startup using a technology developed at the CEA and the CNRS, co-founded by Benoit Larrat, PhD and Anthony Novell, whose
Follow us
Contact us

A question? A project?
Our experts answer you